{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:11:05Z","timestamp":1790428265670,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["824MS157"],"award-info":[{"award-number":["824MS157"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["825MS189"],"award-info":[{"award-number":["825MS189"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["G2021004"],"award-info":[{"award-number":["G2021004"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.critrevonc.2026.105155","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:52:34Z","timestamp":1769442754000},"page":"105155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["FASN at the crossroads of tumor metabolism, immune evasion, and therapy resistance: Mechanistic insights and therapeutic opportunities"],"prefix":"10.1016","volume":"220","author":[{"given":"Xuefeng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio E.","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/crj.12742","article-title":"Smoking and EGFR status may predict outcomes of advanced NSCLC treated with PD-(L)1 inhibitors beyond first line: a meta-analysis","volume":"12","author":"Abdel-Rahman","year":"2018","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.critrevonc.2026.105155_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102569","article-title":"Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress","volume":"59","author":"Abulikemu","year":"2023","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105155_bib3","doi-asserted-by":"crossref","first-page":"16643","DOI":"10.1002\/jcb.28923","article-title":"Pyridine derivatives as anticancer lead compounds with Fatty Acid Synthase as the target: an in silico-guided in vitro study","volume":"120","author":"Amrutha","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105155_bib4","article-title":"Fatty acid synthase-derived lipid stores support breast cancer metastasis","author":"Andolino","year":"2024","journal-title":"Res. Sq."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40170-025-00404-3","article-title":"Fatty acid synthase-derived lipid stores support breast cancer metastasis","volume":"13","author":"Andolino","year":"2025","journal-title":"Cancer Metab."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105155_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007567","article-title":"Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma","volume":"11","author":"Augustin","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"94","key":"10.1016\/j.critrevonc.2026.105155_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn1452","article-title":"The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis","volume":"9","author":"Balasubramanian","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.addr.2020.01.004","article-title":"Fatty acid metabolism in the progression and resolution of CNS disorders","volume":"159","author":"Bogie","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105155_bib9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ni.3532","article-title":"C13orf31 (FAMIN) is a central regulator of immunometabolic function","volume":"17","author":"Cader","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2021.100305","article-title":"Altered protein S-glutathionylation depicts redox imbalance triggered by transition metal oxide nanoparticles in a breastfeeding system","volume":"22","author":"Cai","year":"2021","journal-title":"NanoImpact"},{"key":"10.1016\/j.critrevonc.2026.105155_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1579423","article-title":"Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options","volume":"15","author":"Cai","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib12","doi-asserted-by":"crossref","first-page":"18s","DOI":"10.1177\/0148607115595980","article-title":"Functional roles of fatty acids and their effects on human health","volume":"39","author":"Calder","year":"2015","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-14639-z","article-title":"Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer","volume":"15","author":"Castagnoli","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105155_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13402-023-00769-x","article-title":"Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer","volume":"46","author":"Castagnoli","year":"2023","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1761409","article-title":"The impact of aberrant lipid metabolism on the immune microenvironment of gastric cancer: a mini review","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41416-024-02574-1","article-title":"GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14\/FASN axis and GPX4","volume":"130","author":"Chen","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12915-023-01698-9","article-title":"High-intensity interval training induces lactylation of fatty acid synthase to inhibit lipid synthesis","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105155_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/09553002.2024.2446585","article-title":"FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer","volume":"101","author":"Chen","year":"2025","journal-title":"Int. J. Radiat. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105155_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100660","article-title":"Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN\/APP axis as novel therapeutic strategies","volume":"65","author":"Chen","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.critrevonc.2026.105155_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/mi\/4955849","article-title":"METTL3\/miR-192-5p\/SCD1 axis regulates lipid metabolism to affect T cell differentiation in asthma","volume":"2025","author":"Chen","year":"2025","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.critrevonc.2026.105155_bib21","article-title":"CircWHSC1 promotes breast cancer progression by regulating the FASN\/AMPK\/mTOR Axis Through Sponging miR-195-5p","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5582\/ddt.2023.01036","article-title":"FASN promotes gallbladder cancer progression and reduces cancer cell sensitivity to gemcitabine through PI3K\/AKT signaling","volume":"17","author":"Cheng","year":"2023","journal-title":"Drug Discov. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49486-2","article-title":"Fatty acid inhibition sensitizes androgen-dependent and -independent prostate cancer to radiotherapy via FASN\/NF-\u03baB Pathway","volume":"9","author":"Chuang","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105155_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MOL.0b013e3281574570","article-title":"Lipid metabolism and metabolic disease: defining new targets","volume":"18","author":"Cohn","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41420-024-02184-z","article-title":"Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity","volume":"10","author":"Cuy\u00e0s","year":"2024","journal-title":"Cell death Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1158\/2767-9764.CRC-23-0248","article-title":"FASN gene methylation is associated with fatty acid synthase expression and clinical-genomic features of prostate cancer","volume":"4","author":"Dairo","year":"2024","journal-title":"Cancer Res. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12951-025-03228-x","article-title":"Naringenin cationic lipid-modified nanoparticles mitigate MASLD progression by modulating lipid homeostasis and gut microbiota","volume":"23","author":"Dong","year":"2025","journal-title":"J. Nanobiotech."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41419-022-04926-2","article-title":"FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis","volume":"13","author":"Du","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105155_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.lfs.2019.03.056","article-title":"Clinical importance of FASN in relation to HIF-1\u03b1 and SREBP-1c in gastric adenocarcinoma","volume":"224","author":"Ezzeddini","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105155_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105155_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092741","article-title":"\u03b1-linolenic acid suppresses proliferation and invasion in osteosarcoma cells via inhibiting fatty acid synthase","volume":"27","author":"Fan","year":"2022","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105155_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25173935","article-title":"Fatty acid synthase: an emerging target in cancer","volume":"25","author":"Fhu","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3724\/abbs.2024054","article-title":"DPP3 promotes breast cancer tumorigenesis by stabilizing FASN and promoting lipid synthesis","volume":"56","author":"Fu","year":"2024","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105155_bib34","first-page":"756","article-title":"ACSL4 Regulates LPS-induced ferroptosis in cardiomyocytes through FASN","volume":"54","author":"Gao","year":"2024","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105155_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/PPO.0000000000000491","article-title":"Immunotherapy in EGFR-Mutant and ALK-positive lung cancer: implications for oncogene-driven lung cancer","volume":"26","author":"Gavralidis","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105155_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108198","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib37","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1038\/s41467-023-40975-7","article-title":"CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications","volume":"14","author":"Gong","year":"2023","journal-title":"Nat. Commun."},{"issue":"44","key":"10.1016\/j.critrevonc.2026.105155_bib38","doi-asserted-by":"crossref","first-page":"71151","DOI":"10.18632\/oncotarget.9463","article-title":"Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer","volume":"7","author":"Gonzalez-Guerrico","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105155_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1014798","article-title":"Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin","volume":"10","author":"Granit","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105155_bib40","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41388-020-1156-0","article-title":"Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis","volume":"39","author":"Gu","year":"2020","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105155_bib41","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ccell.2025.04.001","article-title":"Stromal lipid species dictate melanoma metastasis and tropism","volume":"43","author":"Gurung","year":"2025","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105155_bib42","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.3168\/jds.2018-14382","article-title":"Overexpression of SREBF chaperone (SCAP) enhances nuclear SREBP1 translocation to upregulate fatty acid synthase (FASN) gene expression in bovine mammary epithelial cells","volume":"101","author":"Han","year":"2018","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.critrevonc.2026.105155_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103843","article-title":"Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis","volume":"86","author":"Han","year":"2025","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105155_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112303","article-title":"Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING","volume":"42","author":"Heath","year":"2023","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105155_bib45","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-10-3894","article-title":"Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression","volume":"71","author":"Hilvo","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105155_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121745","article-title":"EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647\/FASN axis","volume":"324","author":"Huang","year":"2023","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105155_bib47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/0008-5472.CAN-23-0966","article-title":"FASN Inhibition Decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular carcinoma","volume":"84","author":"Huang","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12964-023-01262-6","article-title":"Roles of Twist1 in lipid and glucose metabolism","volume":"21","author":"Huang","year":"2023","journal-title":"Cell communication signaling CCS"},{"key":"10.1016\/j.critrevonc.2026.105155_bib49","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3389\/fimmu.2018.02927","article-title":"Ovarian cancer-intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-024-01962-8","article-title":"The m(6)A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN","volume":"23","author":"Jiang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib51","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/2211-5463.13137","article-title":"SREBP1\/FASN\/cholesterol axis facilitates radioresistance in colorectal cancer","volume":"11","author":"Jin","year":"2021","journal-title":"FEBS Open bio"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105155_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26125721","article-title":"Downregulation of S6 Kinase and Hedgehog-Gli1 by inhibition of fatty acid synthase in AML with FLT3-ITD Mutation","volume":"26","author":"Kebenko","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105155_bib53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41589-019-0344-0","article-title":"Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation","volume":"15","author":"Kim","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"11-12","key":"10.1016\/j.critrevonc.2026.105155_bib54","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12272-023-01473-y","article-title":"Targeting dysregulated lipid metabolism in the tumor microenvironment","volume":"46","author":"Kim","year":"2023","journal-title":"Arch. Pharmacal. Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105155_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072183","article-title":"Biosynthesis and significance of fatty acids, glycerophospholipids, and triacylglycerol in the processes of glioblastoma tumorigenesis","volume":"15","author":"Korbecki","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s10020-025-01163-z","article-title":"Involvement of microRNAs-449\/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer","volume":"31","author":"Lameirinhas","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105155_bib57","article-title":"Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK\/p300\/SREBP-1c axis","volume":"123","author":"Lan","year":"2024","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105155_bib58","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/cac2.70038","article-title":"Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy","volume":"45","author":"Lao","year":"2025","journal-title":"Cancer Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib59","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s13402-025-01081-6","article-title":"Lipid metabolism in cancer stem cells: reprogramming, mechanisms, crosstalk, and therapeutic approaches","volume":"48","author":"Lee","year":"2025","journal-title":"Cell. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib60","article-title":"The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy","volume":"57","author":"Li","year":"2025","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib61","article-title":"Metformin and berberine synergistically improve NAFLD via the AMPK-SREBP1-FASN signaling pathway","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105155_bib62","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.7150\/ijbs.101039","article-title":"Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.7150\/ijbs.7357","article-title":"Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells","volume":"10","author":"Li","year":"2014","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105155_bib64","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.7150\/ijbs.78535","article-title":"The Emerging role of super-enhancers as therapeutic targets in the digestive system tumors","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105155_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167958","article-title":"TRIM34 inhibits triple-negative breast cancer progression by attenuating fatty acid synthesis via facilitating FASN ubiquitination","volume":"1871","author":"Li","year":"2025","journal-title":"Biochim. Et. Biophys. Acta Mol. basis Dis."},{"issue":"34","key":"10.1016\/j.critrevonc.2026.105155_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202504688","article-title":"Gut Parabacteroides distasonis-derived Indole-3-acetic acid promotes phospholipid remodeling and enhances ferroptosis sensitivity via the AhR-FASN Axis in Bladder Cancer","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib67","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","article-title":"Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis","volume":"42","author":"Li","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41419-025-07500-8","article-title":"Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1\/FASN\/ACC pathway and anti-inflammatory effect of IL10","volume":"16","author":"Li","year":"2025","journal-title":"Cell death Dis."},{"key":"10.1016\/j.critrevonc.2026.105155_bib69","article-title":"Resveratrol attenuated fatty acid synthesis through MAPK-PPAR pathway in red tilapia","volume":"268","author":"Li","year":"2023","journal-title":"Comp. Biochem. Phys. Toxicol. Pharma."},{"issue":"108","key":"10.1016\/j.critrevonc.2026.105155_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado3485","article-title":"Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma","volume":"10","author":"Liang","year":"2025","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12967-024-04931-3","article-title":"PITPNC1 Suppress CD8(+) T cell immune function and promote radioresistance in rectal cancer by modulating FASN\/CD155","volume":"22","author":"Liang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105155_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13111277","article-title":"Ferulic acid alleviates lipid and bile acid metabolism disorders by targeting FASN and CYP7A1 in Iron Overload-Treated Mice","volume":"13","author":"Liang","year":"2024","journal-title":"Antioxidants"},{"issue":"7849","key":"10.1016\/j.critrevonc.2026.105155_bib73","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","article-title":"Lipid signalling enforces functional specialization of T(reg) cells in tumours","volume":"591","author":"Lim","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","article-title":"Metabolic reprogramming in the tumor microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105155_bib75","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1007\/s00210-024-03174-9","article-title":"USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis","volume":"397","author":"Liu","year":"2024","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41420-025-02409-9","article-title":"FASN promotes lipid metabolism and progression in colorectal cancer via the SP1\/PLA2G4B axis","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib77","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41467-025-57099-9","article-title":"Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41375-023-02130-5","article-title":"Targeting ZDHHC21\/FASN axis for the treatment of diffuse large B-cell lymphoma","volume":"38","author":"Liu","year":"2024","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib79","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN Inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib80","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3892\/ijo.2010.877","article-title":"Thiazolidinediones\/PPAR\u03b3 agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer","volume":"38","author":"Mansour","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105155_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115064","article-title":"Metabolic reprogramming, sensing, and cancer therapy","volume":"43","author":"Mao","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2026.105155_bib82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2026.105155_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106274","article-title":"Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer","volume":"150","author":"Meijuan","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105155_bib84","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105155_bib85","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14728222.2017.1381087","article-title":"Fatty acid synthase (FASN) as a therapeutic target in breast cancer","volume":"21","author":"Menendez","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib86","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2022.2077189","article-title":"Fatty acid synthase: a druggable driver of breast cancer brain metastasis","volume":"26","author":"Menendez","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","article-title":"ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis","volume":"23","author":"Mo","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105155_bib88","article-title":"Identification of Fasnall as a therapeutically effective Complex I inhibitor","author":"Mukha","year":"2024","journal-title":"bioRxiv Prepr. Serv. Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105155_bib89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/10799893.2018.1511730","article-title":"In silico screening for identification of fatty acid synthase inhibitors and evaluation of their antiproliferative activity using human cancer cell lines","volume":"38","author":"Nisthul","year":"2018","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.critrevonc.2026.105155_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104910","article-title":"Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors","volume":"214","author":"Nuzzo","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib91","article-title":"FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models","volume":"12","author":"O'Farrell","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105155_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib93","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jmb.2010.01.066","article-title":"Structure of the human fatty acid synthase KS-MAT didomain as a framework for inhibitor design","volume":"397","author":"Pappenberger","year":"2010","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib94","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12967-024-05517-9","article-title":"Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer","volume":"22","author":"Papulino","year":"2024","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4132\/jptm.2021.10.27","article-title":"Fatty acid synthetase expression in triple-negative breast cancer","volume":"56","author":"Park","year":"2022","journal-title":"J. Pathol. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib96","first-page":"289","article-title":"FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination","volume":"44","author":"Qian","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.critrevonc.2026.105155_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113407","article-title":"A novel small-molecule fatty acid synthase inhibitor with antitumor activity by cell cycle arrest and cell division inhibition","volume":"219","author":"Qu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105155_bib98","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.2174\/0929867330666230607104441","article-title":"PaSTe. blockade of the lipid phenotype of prostate cancer as metabolic therapy: a theoretical proposal","volume":"31","author":"Romo-Perez","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib99","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/13543784.2018.1471132","article-title":"Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy","volume":"27","author":"Schcolnik-Cabrera","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105155_bib100","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41556-024-01464-1","article-title":"Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition","volume":"26","author":"Schwab","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1334844","article-title":"Spatial transcriptomics reveals altered lipid metabolism and inflammation-related gene expression of sebaceous glands in psoriasis and atopic dermatitis","volume":"15","author":"Seiringer","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105155_bib102","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbalip.2017.12.012","article-title":"FASN-TGF-\u03b21-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells","volume":"1863","author":"Shen","year":"2018","journal-title":"Biochim. Et. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105155_bib103","article-title":"Retraction notice to \"FASN-TGF-\u03b21-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells\" [BBA - Molecular and Cell Biology of Lipids 1863\/3 (March 2018) 313-322]","volume":"1866","author":"Shen","year":"2021","journal-title":"Biochim. Et. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105155_bib104","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41419-023-06090-7","article-title":"The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling","volume":"14","author":"Shi","year":"2023","journal-title":"Cell death Dis."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105155_bib105","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2174\/1389557520666200811100845","article-title":"Recent advances in the development of fatty acid synthase inhibitors as anticancer agents","volume":"20","author":"Singh","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105155_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105155_bib107","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1002\/jcp.27129","article-title":"Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT\/mTOR\/SREBP-1c axis","volume":"234","author":"Tao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib108","series-title":"Food chemical toxicology international journal published British Industrial Biological Research Association","article-title":"Echinacoside ameliorates alcohol-induced oxidative stress and hepatic steatosis by affecting SREBP1c\/FASN pathway via PPAR\u03b1","author":"Tao","year":"2021"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105155_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137283","article-title":"Targeting the SREBP-1\/Hsa-Mir-497\/SCAP\/FASN oncometabolic axis inhibits the cancer stem-like and chemoresistant phenotype of non-small cell lung carcinoma cells","volume":"23","author":"Tiong","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105155_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102396","article-title":"Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer","volume":"56","author":"Wang","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib111","article-title":"FASN promotes the stemness of cancer stem cells and protects colorectal cancer cells from ferroptosis by inhibiting the activation of SREBP2","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib112","article-title":"Jianpi Yangzheng Xiaozheng granule induced ferroptosis to suppress gastric cancer progression through reprogramming lipid metabolism via SCD1\/Wnt\/\u03b2-catenin axis","volume":"12","author":"Wang","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105155_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225638","article-title":"Fatty acid synthase mutations predict favorable immune checkpoint inhibitor outcome and response in melanoma and non-small cell lung cancer patients","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib114","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12944-024-02360-1","article-title":"NAT10 promotes liver lipogenesis in mouse through N4-acetylcytidine modification of Srebf1 and Scap mRNA","volume":"23","author":"Wang","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2013.09.024","article-title":"Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2\/PI3K\/AKT signaling pathway in vitro","volume":"440","author":"Wang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105155_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40388","article-title":"REV-ERB\u03b1 inhibitor rescues MPTP\/MPP(+)-induced ferroptosis of dopaminergic neuron through regulating FASN\/SCD1 signaling pathway","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105155_bib117","first-page":"276","article-title":"Effect of lipid-induced macrophage M1\/M2 polarization on lipid metabolism in hepatocytes","volume":"26","author":"Wang","year":"2018","journal-title":"Chin. J. Hepatol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105155_bib118","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tem.2024.08.009","article-title":"Metabolic reprogramming of macrophages in cancer therapy","volume":"36","author":"Wang","year":"2025","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105155_bib119","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.32359","article-title":"Therapeutic efficacy of FASN inhibition in preclinical models of HCC","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7150\/thno.83051","article-title":"MK8722 initiates early-stage autophagy while inhibiting late-stage autophagy via FASN-dependent reprogramming of lipid metabolism","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib121","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2023.11.017","article-title":"Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism","volume":"36","author":"Wedan","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib122","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","article-title":"FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth","volume":"8","author":"Wei","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-023-44364-y","article-title":"Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use","volume":"15","author":"Worthmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105155_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150494","article-title":"FASN promotes anoikis resistance in colorectal liver metastases through the ERK1\/2 pathway","volume":"736","author":"Wu","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-024-02024-0","article-title":"Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy","volume":"23","author":"Wu","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.critrevonc.2026.105155_bib126","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jbior.2013.09.004","article-title":"Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments","volume":"54","author":"Wu","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.critrevonc.2026.105155_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217992","article-title":"Synergistic targeting of FASN and HMGCS1 by cerulenin enhances tumor cell ferroptosis sensitivity through rewiring lipid metabolism and blocking GPX4 biosynthesis","volume":"633","author":"Xia","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105155_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113136","article-title":"FASN contributes to the pathogenesis of lupus by promoting TLR-mediated activation of macrophages and dendritic cells","volume":"142","author":"Xiao","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib129","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105155_bib130","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj5942","article-title":"Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease","volume":"10","author":"Xu","year":"2024","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105155_bib131","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166149","article-title":"TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase","volume":"134","author":"Xu","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib132","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2024.03.016","article-title":"FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma","volume":"81","author":"Xu","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110405","article-title":"Mitochondrial targeting nano-curcumin for attenuation on PKM2 and FASN","volume":"182","author":"Yang","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105155_bib134","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.7150\/thno.82920","article-title":"The role of lipid metabolic reprogramming in tumor microenvironment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105155_bib135","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.7150\/ijbs.85285","article-title":"FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression","volume":"19","author":"Ye","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105155_bib136","series-title":"Dual targeting hepatocyte DGAT2 stellate cell FASN alleviates nonalcoholic steatohepatitis mice. bioRxiv preprint server biology","author":"Yenilmez","year":"2023"},{"key":"10.1016\/j.critrevonc.2026.105155_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111306","article-title":"Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation","volume":"405","author":"Yin","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105155_bib138","first-page":"1760","article-title":"[Effect of diosgenin on mTOR\/FASN\/HIF-1\u03b1\/VEGFA expression in rats with non-alcoholic fatty liver disease","volume":"48","author":"Yin","year":"2023","journal-title":"China J. Chin. Mater. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib139","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","article-title":"Contradictory roles of lipid metabolism in immune response within the tumor microenvironment","volume":"14","author":"Yu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105155_bib140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4149\/gpb_2019061","article-title":"AZGP1 suppresses the process of colorectal cancer after upregulating FASN expression via mTOR signal pathway","volume":"39","author":"Yu","year":"2020","journal-title":"Gen. Physiol. Biophys."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105155_bib141","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MOL.0000000000000873","article-title":"Exosomes and lipid metabolism in metabolic and cardiovascular disorders","volume":"34","author":"Zein Abdin","year":"2023","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.critrevonc.2026.105155_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109186","article-title":"Docosahexaenoic acid reverses PD-L1-mediated immune suppression by accelerating its ubiquitin-proteasome degradation","volume":"112","author":"Zhang","year":"2023","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105155_bib143","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2020.01.143","article-title":"MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1","volume":"524","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105155_bib144","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1021\/acsanm.4c06257","article-title":"Tumor Microenvironment-Responsive MnOx-mesoporous carbon nanoparticles for enhanced chemodynamic synergistic antitumor therapy","volume":"8","author":"Zhang","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105155_bib145","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1080\/01635581.2022.2036351","article-title":"FASN Targeted by miR-497-5p regulates cell behaviors in cervical cancer","volume":"74","author":"Zhang","year":"2022","journal-title":"Nutr. Cancer"},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105155_bib146","article-title":"Comprehensive Analysis of FASN in Tumor Immune Infiltration and Prognostic Value for Immunotherapy and Promoter DNA Methylation","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105155_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111778","article-title":"Activation of free fatty acid receptors, FFAR1 and FFAR4, ameliorates ulcerative colitis by promote fatty acid metabolism and mediate macrophage polarization","volume":"130","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib148","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41419-025-07886-5","article-title":"YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer","volume":"16","author":"Zhao","year":"2025","journal-title":"Cell death Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib149","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2403197","article-title":"FASN contributes to ADM resistance of diffuse large B-cell lymphoma by inhibiting ferroptosis via nf-\u03baB\/STAT3\/GPX4 axis","volume":"25","author":"Zhong","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105155_bib150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12967-024-04867-8","article-title":"Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Transl. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:56:16Z","timestamp":1776974176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":150,"alternative-id":["S1040842826000429"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105155","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FASN at the crossroads of tumor metabolism, immune evasion, and therapy resistance: Mechanistic insights and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105155"}}